 | • レポートコード：MRC2Q12-19474 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ゾルミトリプタン錠剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ゾルミトリプタン錠剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ゾルミトリプタン錠剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ゾルミトリプタン錠剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのゾルミトリプタン錠剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のゾルミトリプタン錠剤の売上および2028年までの予測に焦点を当てています。 ゾルミトリプタン錠剤のグローバル主要企業には、XI AN DAHENG PHARMACEUTICAL CO..LTD、Chengdu Tiantai Mount Pharmaceutical、Venturepharm Pharmaceuticals、Hunan Jinsa Pharmaceutical、Sichuan Xuhui Pharmaceutical Co., Ltd.、SMS Pharmaceuticals、Midas Pharma、Sinopharm Chuankang Pharmacetuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ゾルミトリプタン錠剤市場は、タイプとアプリケーションによって区分されます。世界のゾルミトリプタン錠剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 2.5mg※2錠剤、2.5mg※6錠剤 【アプリケーション別セグメント】 病院薬局、小売店薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ゾルミトリプタン錠剤製品概要 - タイプ別市場（2.5mg※2錠剤、2.5mg※6錠剤） - アプリケーション別市場（病院薬局、小売店薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のゾルミトリプタン錠剤販売量予測2017-2028 - 世界のゾルミトリプタン錠剤売上予測2017-2028 - ゾルミトリプタン錠剤の地域別販売量 - ゾルミトリプタン錠剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ゾルミトリプタン錠剤販売量 - 主要メーカー別ゾルミトリプタン錠剤売上 - 主要メーカー別ゾルミトリプタン錠剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（2.5mg※2錠剤、2.5mg※6錠剤） - ゾルミトリプタン錠剤のタイプ別販売量 - ゾルミトリプタン錠剤のタイプ別売上 - ゾルミトリプタン錠剤のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、その他） - ゾルミトリプタン錠剤のアプリケーション別販売量 - ゾルミトリプタン錠剤のアプリケーション別売上 - ゾルミトリプタン錠剤のアプリケーション別価格 ・北米市場 - 北米のゾルミトリプタン錠剤市場規模（タイプ別、アプリケーション別） - 主要国別のゾルミトリプタン錠剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのゾルミトリプタン錠剤市場規模（タイプ別、アプリケーション別） - 主要国別のゾルミトリプタン錠剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のゾルミトリプタン錠剤市場規模（タイプ別、アプリケーション別） - 主要国別のゾルミトリプタン錠剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のゾルミトリプタン錠剤市場規模（タイプ別、アプリケーション別） - 主要国別のゾルミトリプタン錠剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのゾルミトリプタン錠剤市場規模（タイプ別、アプリケーション別） - 主要国別のゾルミトリプタン錠剤市場規模（トルコ、サウジアラビア） ・企業情報 XI AN DAHENG PHARMACEUTICAL CO..LTD、Chengdu Tiantai Mount Pharmaceutical、Venturepharm Pharmaceuticals、Hunan Jinsa Pharmaceutical、Sichuan Xuhui Pharmaceutical Co., Ltd.、SMS Pharmaceuticals、Midas Pharma、Sinopharm Chuankang Pharmacetutical ・産業チェーン及び販売チャネル分析 - ゾルミトリプタン錠剤の産業チェーン分析 - ゾルミトリプタン錠剤の原材料 - ゾルミトリプタン錠剤の生産プロセス - ゾルミトリプタン錠剤の販売及びマーケティング - ゾルミトリプタン錠剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ゾルミトリプタン錠剤の産業動向 - ゾルミトリプタン錠剤のマーケットドライバー - ゾルミトリプタン錠剤の課題 - ゾルミトリプタン錠剤の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Zolmitriptan Tablets Market
Due to the COVID-19 pandemic, the global Zolmitriptan Tablets market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 2.5mg*2 Tablets accounting for % of the Zolmitriptan Tablets global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Zolmitriptan Tablets market size is valued at US$ million in 2021, while the US and Europe Zolmitriptan Tablets are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Zolmitriptan Tablets landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Zolmitriptan Tablets include XI AN DAHENG PHARMACEUTICAL CO..LTD, Chengdu Tiantai Mount Pharmaceutical, Venturepharm Pharmaceuticals, Hunan Jinsa Pharmaceutical, Sichuan Xuhui Pharmaceutical Co., Ltd., SMS Pharmaceuticals, Midas Pharma and Sinopharm Chuankang Pharmacetutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Zolmitriptan Tablets Scope and Segment
Zolmitriptan Tablets market is segmented by Specification and by Application. Players, stakeholders, and other participants in the global Zolmitriptan Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Specification and by Application for the period 2017-2028.
Segment by Specification
2.5mg*2 Tablets
2.5mg*6 Tablets
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
XI AN DAHENG PHARMACEUTICAL CO..LTD
Chengdu Tiantai Mount Pharmaceutical
Venturepharm Pharmaceuticals
Hunan Jinsa Pharmaceutical
Sichuan Xuhui Pharmaceutical Co., Ltd.
SMS Pharmaceuticals
Midas Pharma
Sinopharm Chuankang Pharmacetutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Zolmitriptan Tablets Product Introduction
1.2 Market by Specification
1.2.1 Global Zolmitriptan Tablets Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 2.5mg*2 Tablets
1.2.3 2.5mg*6 Tablets
1.3 Market by Application
1.3.1 Global Zolmitriptan Tablets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Zolmitriptan Tablets Sales Estimates and Forecasts 2017-2028
2.2 Global Zolmitriptan Tablets Revenue Estimates and Forecasts 2017-2028
2.3 Global Zolmitriptan Tablets Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Zolmitriptan Tablets Sales by Region
2.4.1 Global Zolmitriptan Tablets Sales by Region (2017-2022)
2.4.2 Global Sales Zolmitriptan Tablets by Region (2023-2028)
2.5 Global Zolmitriptan Tablets Revenue by Region
2.5.1 Global Zolmitriptan Tablets Revenue by Region (2017-2022)
2.5.2 Global Zolmitriptan Tablets Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Zolmitriptan Tablets Sales by Manufacturers
3.1.1 Global Top Zolmitriptan Tablets Manufacturers by Sales (2017-2022)
3.1.2 Global Zolmitriptan Tablets Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Zolmitriptan Tablets in 2021
3.2 Global Zolmitriptan Tablets Revenue by Manufacturers
3.2.1 Global Zolmitriptan Tablets Revenue by Manufacturers (2017-2022)
3.2.2 Global Zolmitriptan Tablets Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Zolmitriptan Tablets Revenue in 2021
3.3 Global Zolmitriptan Tablets Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Zolmitriptan Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Zolmitriptan Tablets Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Zolmitriptan Tablets Sales by Specification
4.1.1 Global Zolmitriptan Tablets Historical Sales by Specification (2017-2022)
4.1.2 Global Zolmitriptan Tablets Forecasted Sales by Specification (2023-2028)
4.1.3 Global Zolmitriptan Tablets Sales Market Share by Specification (2017-2028)
4.2 Global Zolmitriptan Tablets Revenue by Specification
4.2.1 Global Zolmitriptan Tablets Historical Revenue by Specification (2017-2022)
4.2.2 Global Zolmitriptan Tablets Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Zolmitriptan Tablets Revenue Market Share by Specification (2017-2028)
4.3 Global Zolmitriptan Tablets Price by Specification
4.3.1 Global Zolmitriptan Tablets Price by Specification (2017-2022)
4.3.2 Global Zolmitriptan Tablets Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Zolmitriptan Tablets Sales by Application
5.1.1 Global Zolmitriptan Tablets Historical Sales by Application (2017-2022)
5.1.2 Global Zolmitriptan Tablets Forecasted Sales by Application (2023-2028)
5.1.3 Global Zolmitriptan Tablets Sales Market Share by Application (2017-2028)
5.2 Global Zolmitriptan Tablets Revenue by Application
5.2.1 Global Zolmitriptan Tablets Historical Revenue by Application (2017-2022)
5.2.2 Global Zolmitriptan Tablets Forecasted Revenue by Application (2023-2028)
5.2.3 Global Zolmitriptan Tablets Revenue Market Share by Application (2017-2028)
5.3 Global Zolmitriptan Tablets Price by Application
5.3.1 Global Zolmitriptan Tablets Price by Application (2017-2022)
5.3.2 Global Zolmitriptan Tablets Price Forecast by Application (2023-2028)
6 North America
6.1 North America Zolmitriptan Tablets Market Size by Specification
6.1.1 North America Zolmitriptan Tablets Sales by Specification (2017-2028)
6.1.2 North America Zolmitriptan Tablets Revenue by Specification (2017-2028)
6.2 North America Zolmitriptan Tablets Market Size by Application
6.2.1 North America Zolmitriptan Tablets Sales by Application (2017-2028)
6.2.2 North America Zolmitriptan Tablets Revenue by Application (2017-2028)
6.3 North America Zolmitriptan Tablets Market Size by Country
6.3.1 North America Zolmitriptan Tablets Sales by Country (2017-2028)
6.3.2 North America Zolmitriptan Tablets Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Zolmitriptan Tablets Market Size by Specification
7.1.1 Europe Zolmitriptan Tablets Sales by Specification (2017-2028)
7.1.2 Europe Zolmitriptan Tablets Revenue by Specification (2017-2028)
7.2 Europe Zolmitriptan Tablets Market Size by Application
7.2.1 Europe Zolmitriptan Tablets Sales by Application (2017-2028)
7.2.2 Europe Zolmitriptan Tablets Revenue by Application (2017-2028)
7.3 Europe Zolmitriptan Tablets Market Size by Country
7.3.1 Europe Zolmitriptan Tablets Sales by Country (2017-2028)
7.3.2 Europe Zolmitriptan Tablets Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Zolmitriptan Tablets Market Size by Specification
8.1.1 Asia Pacific Zolmitriptan Tablets Sales by Specification (2017-2028)
8.1.2 Asia Pacific Zolmitriptan Tablets Revenue by Specification (2017-2028)
8.2 Asia Pacific Zolmitriptan Tablets Market Size by Application
8.2.1 Asia Pacific Zolmitriptan Tablets Sales by Application (2017-2028)
8.2.2 Asia Pacific Zolmitriptan Tablets Revenue by Application (2017-2028)
8.3 Asia Pacific Zolmitriptan Tablets Market Size by Region
8.3.1 Asia Pacific Zolmitriptan Tablets Sales by Region (2017-2028)
8.3.2 Asia Pacific Zolmitriptan Tablets Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Zolmitriptan Tablets Market Size by Specification
9.1.1 Latin America Zolmitriptan Tablets Sales by Specification (2017-2028)
9.1.2 Latin America Zolmitriptan Tablets Revenue by Specification (2017-2028)
9.2 Latin America Zolmitriptan Tablets Market Size by Application
9.2.1 Latin America Zolmitriptan Tablets Sales by Application (2017-2028)
9.2.2 Latin America Zolmitriptan Tablets Revenue by Application (2017-2028)
9.3 Latin America Zolmitriptan Tablets Market Size by Country
9.3.1 Latin America Zolmitriptan Tablets Sales by Country (2017-2028)
9.3.2 Latin America Zolmitriptan Tablets Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Zolmitriptan Tablets Market Size by Specification
10.1.1 Middle East and Africa Zolmitriptan Tablets Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Zolmitriptan Tablets Revenue by Specification (2017-2028)
10.2 Middle East and Africa Zolmitriptan Tablets Market Size by Application
10.2.1 Middle East and Africa Zolmitriptan Tablets Sales by Application (2017-2028)
10.2.2 Middle East and Africa Zolmitriptan Tablets Revenue by Application (2017-2028)
10.3 Middle East and Africa Zolmitriptan Tablets Market Size by Country
10.3.1 Middle East and Africa Zolmitriptan Tablets Sales by Country (2017-2028)
10.3.2 Middle East and Africa Zolmitriptan Tablets Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 XI AN DAHENG PHARMACEUTICAL CO..LTD
11.1.1 XI AN DAHENG PHARMACEUTICAL CO..LTD Corporation Information
11.1.2 XI AN DAHENG PHARMACEUTICAL CO..LTD Overview
11.1.3 XI AN DAHENG PHARMACEUTICAL CO..LTD Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 XI AN DAHENG PHARMACEUTICAL CO..LTD Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 XI AN DAHENG PHARMACEUTICAL CO..LTD Recent Developments
11.2 Chengdu Tiantai Mount Pharmaceutical
11.2.1 Chengdu Tiantai Mount Pharmaceutical Corporation Information
11.2.2 Chengdu Tiantai Mount Pharmaceutical Overview
11.2.3 Chengdu Tiantai Mount Pharmaceutical Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Chengdu Tiantai Mount Pharmaceutical Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments
11.3 Venturepharm Pharmaceuticals
11.3.1 Venturepharm Pharmaceuticals Corporation Information
11.3.2 Venturepharm Pharmaceuticals Overview
11.3.3 Venturepharm Pharmaceuticals Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Venturepharm Pharmaceuticals Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Venturepharm Pharmaceuticals Recent Developments
11.4 Hunan Jinsa Pharmaceutical
11.4.1 Hunan Jinsa Pharmaceutical Corporation Information
11.4.2 Hunan Jinsa Pharmaceutical Overview
11.4.3 Hunan Jinsa Pharmaceutical Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hunan Jinsa Pharmaceutical Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hunan Jinsa Pharmaceutical Recent Developments
11.5 Sichuan Xuhui Pharmaceutical Co., Ltd.
11.5.1 Sichuan Xuhui Pharmaceutical Co., Ltd. Corporation Information
11.5.2 Sichuan Xuhui Pharmaceutical Co., Ltd. Overview
11.5.3 Sichuan Xuhui Pharmaceutical Co., Ltd. Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sichuan Xuhui Pharmaceutical Co., Ltd. Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sichuan Xuhui Pharmaceutical Co., Ltd. Recent Developments
11.6 SMS Pharmaceuticals
11.6.1 SMS Pharmaceuticals Corporation Information
11.6.2 SMS Pharmaceuticals Overview
11.6.3 SMS Pharmaceuticals Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 SMS Pharmaceuticals Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 SMS Pharmaceuticals Recent Developments
11.7 Midas Pharma
11.7.1 Midas Pharma Corporation Information
11.7.2 Midas Pharma Overview
11.7.3 Midas Pharma Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Midas Pharma Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Midas Pharma Recent Developments
11.8 Sinopharm Chuankang Pharmacetutical
11.8.1 Sinopharm Chuankang Pharmacetutical Corporation Information
11.8.2 Sinopharm Chuankang Pharmacetutical Overview
11.8.3 Sinopharm Chuankang Pharmacetutical Zolmitriptan Tablets Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Sinopharm Chuankang Pharmacetutical Zolmitriptan Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sinopharm Chuankang Pharmacetutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Zolmitriptan Tablets Industry Chain Analysis
12.2 Zolmitriptan Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Zolmitriptan Tablets Production Mode & Process
12.4 Zolmitriptan Tablets Sales and Marketing
12.4.1 Zolmitriptan Tablets Sales Channels
12.4.2 Zolmitriptan Tablets Distributors
12.5 Zolmitriptan Tablets Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Zolmitriptan Tablets Industry Trends
13.2 Zolmitriptan Tablets Market Drivers
13.3 Zolmitriptan Tablets Market Challenges
13.4 Zolmitriptan Tablets Market Restraints
14 Key Findings in The Global Zolmitriptan Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer